NO940777L - Anvendelse av et pregnanderivat - Google Patents

Anvendelse av et pregnanderivat

Info

Publication number: NO940777L
Authority: NO; Norway
Prior art keywords: derivative; pregnancy; alpha; pregnane; oacyl
Prior art date: 1993-03-05

Application number

NO940777A

Other languages

English (en)

Other versions

NO307447B1 (no

NO940777D0 (no

Inventor

Godefridus Hermanus Jo Deckers

Helenius Jan Kloosterboer

Original Assignee

Akzo Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-05

Filing date

1994-03-04

Publication date

1994-09-06

1994-03-04 Application filed by Akzo Nv filed Critical Akzo Nv

1994-03-04 Publication of NO940777D0 publication Critical patent/NO940777D0/no

1994-09-06 Publication of NO940777L publication Critical patent/NO940777L/no

2000-04-10 Publication of NO307447B1 publication Critical patent/NO307447B1/no

Links

230000035935 pregnancy Effects 0.000 title 1
150000003126 pregnane derivatives Chemical class 0.000 abstract 2
101100241859 Mus musculus Oacyl gene Proteins 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Fats And Perfumes (AREA)

NO940777A 1993-03-05 1994-03-04 Anvendelse av et pregnanderivat NO307447B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP93200631		1993-03-05

Publications (3)

Publication Number	Publication Date
NO940777D0 NO940777D0 (no)	1994-03-04
NO940777L true NO940777L (no)	1994-09-06
NO307447B1 NO307447B1 (no)	2000-04-10

Family

ID=8213673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO940777A NO307447B1 (no)	1993-03-05	1994-03-04	Anvendelse av et pregnanderivat

Country Status (14)

Country	Link
US (1)	US5512556A (no)
EP (1)	EP0613687B1 (no)
JP (1)	JP3391539B2 (no)
KR (1)	KR100312061B1 (no)
AT (1)	ATE180669T1 (no)
AU (1)	AU671706B2 (no)
CA (1)	CA2116829C (no)
DE (1)	DE69418744T2 (no)
DK (1)	DK0613687T3 (no)
ES (1)	ES2134313T3 (no)
GR (1)	GR3031114T3 (no)
NO (1)	NO307447B1 (no)
NZ (1)	NZ260017A (no)
ZA (1)	ZA941464B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4334616B2 (ja) *	1994-09-22	2009-09-30	ナームローゼ・フエンノートチヤツプ・オルガノン	湿式粒状化による投与単位体を製造する方法
IL123984A (en)	1997-04-22	2004-09-27	Akzo Nobel Nv	Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
EP1121375B1 (en) *	1998-10-16	2003-05-02	Akzo Nobel N.V.	High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
ATE246703T1 (de) *	1999-04-06	2003-08-15	Akzo Nobel Nv	Oral wirksame 7-alpha-alkyl androgene
US6677329B1 (en)	1999-09-06	2004-01-13	Akzo Nobel N V.	Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
AU8201601A (en)	2000-07-28	2002-02-13	Akzo Nobel Nv	16alpha-methyl or ethyl substituted estrogens
WO2003032924A2 (en) *	2001-10-18	2003-04-24	Ivax Corporation	Novel tibolone formulations
GB0125061D0 (en) *	2001-10-18	2001-12-12	Norton Healthcare Ltd	Pharmaceutical composition
JP2005518412A (ja) *	2002-01-22	2005-06-23	アクゾ・ノベル・エヌ・ベー	内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン
HRP20050430A2 (en) *	2002-11-20	2005-06-30	Akzo Nobel N.V.	Pharmaceutical tablets containing tibolone and a coating
UA89964C2 (ru)	2004-09-08	2010-03-25	Н.В. Органон	15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US20060211667A1 (en) *	2005-03-21	2006-09-21	Eric Marchewitz	Use of pregnane steroid derivatives for enhancing physical performance
CN116987680A (zh) *	2022-04-25	2023-11-03	复旦大学	支链氨基酸转氨酶1的功能获得性突变体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3515719A (en)	1967-03-15	1970-06-02	Upjohn Co	7-methyl-6,19-epoxy steroids of the androstane series
US4701450A (en) *	1984-03-21	1987-10-20	Akzo N.V.	Steroids for use as immunomodulators
IE63051B1 (en) *	1989-03-18	1995-03-22	Akzo Nv	Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
FR2706454B1 (fr) *	1993-06-17	1995-09-15	Roussel Uclaf	Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.

1994
- 1994-03-02 ES ES94200523T patent/ES2134313T3/es not_active Expired - Lifetime
- 1994-03-02 AT AT94200523T patent/ATE180669T1/de not_active IP Right Cessation
- 1994-03-02 DE DE69418744T patent/DE69418744T2/de not_active Expired - Fee Related
- 1994-03-02 AU AU57542/94A patent/AU671706B2/en not_active Ceased
- 1994-03-02 DK DK94200523T patent/DK0613687T3/da active
- 1994-03-02 EP EP94200523A patent/EP0613687B1/en not_active Expired - Lifetime
- 1994-03-02 ZA ZA941464A patent/ZA941464B/xx unknown
- 1994-03-02 CA CA002116829A patent/CA2116829C/en not_active Expired - Fee Related
- 1994-03-03 NZ NZ260017A patent/NZ260017A/en not_active IP Right Cessation
- 1994-03-04 NO NO940777A patent/NO307447B1/no unknown
- 1994-03-04 KR KR1019940004180A patent/KR100312061B1/ko not_active Expired - Fee Related
- 1994-03-04 JP JP03454094A patent/JP3391539B2/ja not_active Expired - Fee Related
- 1994-12-19 US US08/358,639 patent/US5512556A/en not_active Expired - Fee Related
1999
- 1999-08-31 GR GR990402196T patent/GR3031114T3/el unknown

Also Published As

Publication number	Publication date
JPH072673A (ja)	1995-01-06
US5512556A (en)	1996-04-30
EP0613687B1 (en)	1999-06-02
EP0613687A1 (en)	1994-09-07
JP3391539B2 (ja)	2003-03-31
DK0613687T3 (da)	1999-12-06
GR3031114T3 (en)	1999-12-31
ZA941464B (en)	1994-09-27
DE69418744D1 (de)	1999-07-08
CA2116829A1 (en)	1994-09-06
ATE180669T1 (de)	1999-06-15
KR100312061B1 (ko)	2001-12-28
DE69418744T2 (de)	1999-11-11
NO307447B1 (no)	2000-04-10
NZ260017A (en)	1997-06-24
CA2116829C (en)	2004-09-14
AU5754294A (en)	1994-09-08
NO940777D0 (no)	1994-03-04
ES2134313T3 (es)	1999-10-01
AU671706B2 (en)	1996-09-05
KR940021064A (ko)	1994-10-17

Similar Documents

Publication	Publication Date	Title
RU2088589C1 (en)	1997-08-27	Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
IL136044A (en)	2005-08-31	2-aminoacetamide derivatives and pharmaceutical compositions containing the same
LU90856I2 (fr)	2002-01-24	Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
AU7815791A (en)	1992-01-02	Heterocyclene derivatives
HU9600834D0 (en)	1996-05-28	Quinazoline derivatives
EP0807633A3 (en)	1998-05-13	Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
IL175398A0 (en)	2006-09-05	Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
DK0694545T3 (da)	2000-09-18	Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
NO940777L (no)	1994-09-06	Anvendelse av et pregnanderivat
HUP9802762A2 (hu)	1999-10-28	Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
MD1560F2 (en)	2000-11-30	Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
TW223016B (no)	1994-05-01
MY114282A (en)	2002-09-30	Anthracycline derivatives
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
HUT70757A (en)	1995-10-30	Pharmaceutical compositions for treating skin disorders
IL131380A0 (en)	2001-01-28	The use of a compound for the manufacture of a pharmaceutical preparatin for the treatment or prevention of prostate cancer
NO903291D0 (no)	1990-07-24	Renin-hemmende aminooligohydroksy-derivater.
AP9400608A0 (en)	1995-07-12	"New nicotinic acid derivative".
PT777471E (pt)	2003-04-30	Metodo de inibicao da biosintese de leucotrieno
KR970702869A (ko)	1997-06-10	항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative)
DE3882956D1 (de)	1993-09-09	Gegen die zerebrale insuffizienz wirksame verbindungen.
KR910000786A (ko)	1991-01-30	콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도
PH30180A (en)	1997-01-21	Leustroducsin h its preparation and its therapeutic use
TH10441B (th)	2001-05-18	การใช้อนุพันธ์เพรคเนม